FDA Releases Draft Guidance for Over-the-Counter Aspirin Products Labeled with Cardiovascular Imagery

Summary

The FDA is releasing a draft guidance to encourage the safe use of nonprescription aspirin products by requiring manufacturers to include a statement reminding consumers to consult their healthcare provider before using aspirin for heart-related issues.